135 related articles for article (PubMed ID: 15240818)
1. Oncostatin M-stimulated apical plasma membrane biogenesis requires p27(Kip1)-regulated cell cycle dynamics.
Van IJzendoorn SC; Théard D; Van Der Wouden JM; Visser W; Wojtal KA; Hoekstra D
Mol Biol Cell; 2004 Sep; 15(9):4105-14. PubMed ID: 15240818
[TBL] [Abstract][Full Text] [Related]
2. Anchoring of protein kinase A-regulatory subunit IIalpha to subapically positioned centrosomes mediates apical bile canalicular lumen development in response to oncostatin M but not cAMP.
Wojtal KA; Hoekstra D; van Ijzendoorn SC
Mol Biol Cell; 2007 Jul; 18(7):2745-54. PubMed ID: 17494870
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.
Halfter H; Friedrich M; Resch A; Kullmann M; Stögbauer F; Ringelstein EB; Hengst L
Cancer Res; 2006 Jul; 66(13):6530-9. PubMed ID: 16818624
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M regulates membrane traffic and stimulates bile canalicular membrane biogenesis in HepG2 cells.
van der Wouden JM; van IJzendoorn SC; Hoekstra D
EMBO J; 2002 Dec; 21(23):6409-18. PubMed ID: 12456648
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
7. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.
Boehm M; Yoshimoto T; Crook MF; Nallamshetty S; True A; Nabel GJ; Nabel EG
EMBO J; 2002 Jul; 21(13):3390-401. PubMed ID: 12093740
[TBL] [Abstract][Full Text] [Related]
8. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM
Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
[TBL] [Abstract][Full Text] [Related]
10. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M induces growth arrest of skeletal muscle cells in G1 phase by regulating cyclin D1 protein level.
Kim H; Jo C; Jang BG; Oh U; Jo SA
Cell Signal; 2008 Jan; 20(1):120-9. PubMed ID: 17976956
[TBL] [Abstract][Full Text] [Related]
12. The localization and activity of cAMP-dependent protein kinase affect cell cycle progression in thyroid cells.
Feliciello A; Gallo A; Mele E; Porcellini A; Troncone G; Garbi C; Gottesman ME; Avvedimento EV
J Biol Chem; 2000 Jan; 275(1):303-11. PubMed ID: 10617619
[TBL] [Abstract][Full Text] [Related]
13. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.
Bresnahan WA; Boldogh I; Ma T; Albrecht T; Thompson EA
Cell Growth Differ; 1996 Oct; 7(10):1283-90. PubMed ID: 8891332
[TBL] [Abstract][Full Text] [Related]
14. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
[TBL] [Abstract][Full Text] [Related]
15. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
16. Cyclin dependent kinase inhibitor p27(Kip1) is upregulated by hypoxia via an ARNT dependent pathway.
Wang G; Reisdorph R; Clark RE; Miskimins R; Lindahl R; Miskimins WK
J Cell Biochem; 2003 Oct; 90(3):548-60. PubMed ID: 14523989
[TBL] [Abstract][Full Text] [Related]
17. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A
J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217
[TBL] [Abstract][Full Text] [Related]
18. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
Greider C; Chattopadhyay A; Parkhurst C; Yang E
Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
[TBL] [Abstract][Full Text] [Related]
19. Loss of p27(Kip1) cooperates with cyclin E in T-cell lymphomagenesis.
Geisen C; Karsunky H; Yücel R; Möröy T
Oncogene; 2003 Mar; 22(11):1724-9. PubMed ID: 12642875
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.
Hu X; Zhang X; Zhong Q; Fisher AB; Bryington M; Zuckerman KS
Oncogene; 2001 Oct; 20(47):6840-50. PubMed ID: 11687963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
